Phase III clinical trial - Appareil Digestif
AAS-Lynch
Appareil Digestif
Essai clinique fermé
Public cible
Adulte
Assessment of the Effect of a Daily Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
Description de l'essai
The objective of this study is to look for a preventive effect of low-dose aspirin (100 or 300 mg/d) compared with placebo on new or recurrent colorectal adenomas in patients with Lynch syndrome.
Liens utiles
BRUNO BUECHER
Investigateur principal